DENTAL SUTURE MARKET ANALYSIS

Dental Suture MarketSize and Trends

The Global Dental Sutures Market is estimated to be valued at US$ 176.22 Mn in 2022 and is expected to exhibit a CAGR of 7.1% over the forecast period (2022-2030).

Figure 1. Global Dental Sutures Market Share (%), by Material, 2022

Global Dental Sutures Market– Drivers

Increasing number of inorganic activities such as partnerships by market players is expected to drive the dental suture market over the forecast period. For instance, In December 2021, Healthium Medtech Limited, a company that provides a range of products to support surgical needs, announced a partnership with DKSH Business Unit Healthcare, Asia’s leading partner for healthcare companies. DKSH and Healthium expanded their partnership to encompass Thailand, Cambodia, and Laos, where DKSH will provide full-service representation, manage distribution, and market Healthium's  surgical products.

Figure 2. Global Dental Sutures Market Share (%), by Region, 2022

Global Dental Sutures Market– Impact of Coronavirus (COVID-19) Pandemic:

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it a public health emergency on January 30, 2020. COVID-19 can affect the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others are facing problems with the transportation of drugs from one place to another. Overall Covid- 19 had an negative impact on on the supply and demand of the global dental sutures market. For instance, an article published by PubMed in July 2021, stated that Median outpatient department cases and the number of surgeries (oral and maxillofacial surgery) done per week were reduced by 73.9% and 66.7%, respectively in India. Most surgeons (86%) experienced that cost of treatment had increased during the COVID-19. Over 75% were afraid to get infected with COVID, whereas 44.9% were anxious to lose their income. More than 56% of the oral and maxillofacial surgeons reported a fall in income and 94% reported decreased productivity in academic research.